DNA

Ginkgo Bioworks Holdings (DNA)

About Ginkgo Bioworks Holdings (DNA)

Ginkgo Bioworks Holdings, Inc. engages in developing biological engineering products and custom microbes. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment includes end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through its Canopy and Horizon offerings. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Details

Daily high
$7.65
Daily low
$7.26
Price at open
$7.30
52 Week High
$17.58
52 Week Low
$5.00
Market cap
418.4M
Dividend yield
0.00%
Volume
1.0M
Avg. volume
1.3M
P/E ratio
-1.26

Ginkgo Bioworks Holdings News

Details

Daily high
$7.65
Daily low
$7.26
Price at open
$7.30
52 Week High
$17.58
52 Week Low
$5.00
Market cap
418.4M
Dividend yield
0.00%
Volume
1.0M
Avg. volume
1.3M
P/E ratio
-1.26